Skip to the answer

Amikacin Injection Uses, Dosage, Side Effects and Interactions

Brand name
Amikin

Amikin was the first amikacin injection product the FDA approved, in 1981. The FDA now lists it as discontinued; generic amikacin injection is still listed.

Amikacin Injection is an aminoglycoside antibiotic given by injection or IV for short-term treatment of serious infections caused by susceptible Gram-negative bacteria, and in some cases staphylococci.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About Amikacin InjectionType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Amikacin Injection in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Amikacin is an aminoglycoside antibiotic, used since the early 1980s and with FDA-approved generics listed, that stops Gram-negative bacteria from making proteins and resists some enzymes that defeat gentamicin and tobramycin, so it is usually kept for serious or resistant infections treated in the hospital. For many people a short course brings few side effects they notice, mostly nausea, headache or a rash, but its biggest risks are ones you may not feel. Its boxed warning covers permanent hearing loss, balance problems and kidney damage, so tell the care team right away about ringing or roaring in the ears, dizziness or much less urine.

Key Takeaways From the HelloPharmacist Team

  • Your care team gives it into a muscle or vein two or three times a day, usually for 7 to 10 days.
  • Expect regular blood tests for kidney function and drug levels, plus hearing checks, because the dose is tuned to your weight and kidneys.
  • Report ringing in the ears, muffled hearing or unsteadiness even after the last dose, because hearing damage can surface after treatment ends.
  • Tell the team if you take a water pill such as furosemide or have kidney problems, since both raise the risk of hearing and kidney damage.

How we write and review this content: our editorial policy

FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Amikacin Injection.

Amikacin can cause permanent hearing loss, balance problems and kidney damage. People should be closely watched during treatment.

Risk is higher with existing kidney problems, high doses, long treatment (safety beyond 14 days is not established), older age, and dehydration. Hearing damage may not cause symptoms until after the drug is stopped.

Watch for dizziness, vertigo, ringing or roaring in the ears, hearing loss, numbness, tingling, muscle twitching, and seizures. Breathing muscle weakness can happen, especially with anesthetics or muscle relaxants. Avoid other drugs that harm the ears or kidneys, and strong diuretics such as furosemide. Your team should check kidney function, drug levels and hearing, and may stop or adjust the drug.

Read the full warning on DailyMed →

Amikacin Injection by the Numbers

Strengths
2
in one form
Makers and packagers
6
Earliest FDA record
1981
Rank by Medicaid prescriptions
#1,170 of 1,682 drugs
More prescriptions than 30% of the 1,682 drugs we measure
2,869 prescriptions, Q1–Q4 2025
Other forms and routes

Patient Information Guide for Amikacin Injection

What It’s Used For

Amikacin Injection treats serious bacterial infections for a short time.

  • Serious infections from susceptible Gram-negative bacteria (including Pseudomonas, E. coli, Proteus, Klebsiella, Enterobacter, Serratia, Acinetobacter)
  • Bacterial septicemia, including neonatal sepsis
  • Serious infections of the respiratory tract, bones and joints, central nervous system (including meningitis), and skin and soft tissue
  • Intra-abdominal infections, including peritonitis
  • Burns and postoperative infections
  • Serious complicated and recurrent urinary tract infections
  • Certain staphylococcal infections under specific conditions

How It Works

Amikacin is an aminoglycoside antibiotic. It binds to the ribosome in bacteria and blocks protein production, which kills susceptible bacteria.

It resists some bacterial enzymes that inactivate gentamicin, tobramycin and kanamycin. It does not work against Salmonella and Shigella in patients, and has low activity against Gram-positive bacteria other than staphylococci.

Drug Class

Drug Class

  • Aminoglycoside Antibacterial
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Aminoglycoside Antibacterial

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)

None listed for Amikacin Injection in the FDA’s index.

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Amikacin Injection in the FDA’s index.

From our Patient Information GuideAmikacin is an aminoglycoside antibiotic. It binds to the ribosome in bacteria and blocks protein production, which kills susceptible bacteria. It resists some bacterial enzymes that inactivate gentamicin, tobramycin and kanamycin. Read How Amikacin Injection Works

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)
  • Aminoglycosides

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Other antibiotics for topical use
  • Other aminoglycosides
  • Antibiotics

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

Amikacin Injection is given by a healthcare professional into a muscle or a vein.

  • Usually 2 or 3 times a day, with dose based on body weight
  • Usual course is 7 to 10 days
  • Kidney problems mean a lower dose or longer gaps between doses
  • Blood levels and kidney function are checked during treatment

Follow your prescriber and the label.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Serious infections caused by susceptible Gram-negative bacteria

Adults and children, 45 kg (99 lbs) Usual dose 337.5 mg every 12 hours
  • 337.5 mg (7.5 mg/kg q12h) or 225 mg (5 mg/kg q8h)
Adults and children, 50 kg (110 lbs) Usual dose 375 mg every 12 hours
  • 375 mg (7.5 mg/kg q12h) or 250 mg (5 mg/kg q8h)
Adults and children, 55 kg (121 lbs) Usual dose 412.5 mg every 12 hours
  • 412.5 mg (7.5 mg/kg q12h) or 275 mg (5 mg/kg q8h)
Adults and children, 60 kg (132 lbs) Usual dose 450 mg every 12 hours
  • 450 mg (7.5 mg/kg q12h) or 300 mg (5 mg/kg q8h)
Adults and children, 65 kg (143 lbs) Usual dose 487.5 mg every 12 hours
  • 487.5 mg (7.5 mg/kg q12h) or 325 mg (5 mg/kg q8h)
Adults and children, 70 kg (154 lbs) Usual dose 525 mg every 12 hours
  • 525 mg (7.5 mg/kg q12h) or 350 mg (5 mg/kg q8h)
Adults and children, 75 kg (165 lbs) Usual dose 562.5 mg every 12 hours
  • 562.5 mg (7.5 mg/kg q12h) or 375 mg (5 mg/kg q8h)
Adults and children, 80 kg (176 lbs) Usual dose 600 mg every 12 hours
  • 600 mg (7.5 mg/kg q12h) or 400 mg (5 mg/kg q8h)
Adults and children, 85 kg (187 lbs) Usual dose 637.5 mg every 12 hours
  • 637.5 mg (7.5 mg/kg q12h) or 425 mg (5 mg/kg q8h)
Adults and children, 90 kg (198 lbs) Usual dose 675 mg every 12 hours
  • 675 mg (7.5 mg/kg q12h) or 450 mg (5 mg/kg q8h)
Newborns · Loading dose Starting dose 10 mg/kg once
  • Loading dose of 10 mg/kg initially

What a loading dose is: A larger dose given at the start to quickly build the medicine up to an effective level in the body.

Newborns · After loading dose Usual dose 7.5 mg/kg every 12 hours Highest dose 15 mg/kg/day

Good to know

Usual duration of treatment is 7 to 10 days

What a loading dose is: A larger dose given at the start to quickly build the medicine up to an effective level in the body.

Adults, children and older infants with normal kidney function Usual dose 7.5 mg/kg every 12 hours Highest dose 1.5 gram a day
  • 15 mg/kg/day divided into 2 or 3 equal doses at equally-divided intervals, i.e., 7.5 mg/kg q12h or 5 mg/kg q8h

Good to know

Usual duration of treatment is 7 to 10 days

Urinary tract infections

Usual dose 250 mg twice a day
  • 250 mg twice daily may be used

See the Full Dosing Instructions on DailyMed →

Side Effects

The most important side effects involve the ears, balance and kidneys.

Common side effects

  • Hearing loss or ringing in the ears
  • Dizziness or loss of balance
  • Changes in kidney function tests
  • Skin rash
  • Drug fever
  • Headache
  • Nausea and vomiting
  • Numbness, tingling or tremor
  • Kidney changes, usually reversible after stopping

When to get medical help

  • Tell your care team right away about hearing changes, ringing or roaring in the ears, dizziness, or vertigo (spinning feeling).
  • Report much less urine, swelling, or other signs of kidney trouble.
  • Get urgent help for trouble breathing or muscle weakness or paralysis.
  • Report numbness, skin tingling, muscle twitching or seizures.
  • Call your doctor about diarrhea during or even months after treatment, since it can be a serious C. difficile infection.
  • Seek emergency help for allergic reactions such as wheezing or swelling, especially if you have asthma or sulfite sensitivity.

Report hearing or balance changes, reduced urination, breathing problems, or lasting diarrhea right away.

Warnings and Precautions

  • Permanent hearing loss and kidney damage are the biggest risks, especially with kidney disease, high doses, long treatment, older age or dehydration.
  • Breathing muscle weakness can occur, particularly with anesthetics or muscle relaxants.
  • Can harm an unborn baby.
  • Contains sodium metabisulfite, which can cause allergic reactions.
  • C. difficile diarrhea can occur, even months later.
  • Certain mitochondrial gene variants raise the risk of hearing loss even at normal drug levels.

Interactions

Some drugs add to amikacin's risk of ear, kidney or nerve damage.

  • Other aminoglycosides, vancomycin, polymyxin B, colistin, cisplatin, amphotericin B, bacitracin: more kidney and nerve toxicity
  • Furosemide and ethacrynic acid: can cause hearing damage and raise amikacin toxicity
  • Anesthetics and muscle relaxants: higher risk of breathing muscle weakness
  • Large transfusions of citrate-anticoagulated blood: same risk

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Do not use with a past allergy to amikacin or another aminoglycoside.
  • Tell your doctor about kidney disease.
  • Mention any personal or maternal history of hearing loss from aminoglycosides.
  • Tell your doctor if you are pregnant.
  • Mention asthma or sulfite allergy.
  • Older adults and dehydrated people are at higher risk.

Overdose

In overdose or a toxic reaction, hemodialysis or peritoneal dialysis helps remove amikacin from the blood. In newborns, exchange transfusion may also be considered.

Half-Life and How Your Body Processes It

Amikacin is absorbed quickly after a muscle injection, reaching peak blood levels in about 1 hour. The half-life is a little over 2 hours in people with normal kidneys. It is cleared mostly unchanged by the kidneys, with about 98% in urine within 24 hours after an injection into a muscle. With kidney impairment it clears much more slowly, so doses are adjusted. It reaches many tissues and fluids and crosses the placenta.

Storage

Store at 20° to 25°C (68° to 77°F).

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Amikacin Injection: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Amikacin Injection — the kind of thing our pharmacy team would talk through with you at the counter.

What is amikacin injection used for?

It treats serious bacterial infections, mostly from Gram-negative bacteria. These include infections of the blood, lungs, bones, skin, abdomen, and urinary tract, and meningitis. It is used for a short time.

How long will I be on amikacin injection?

Treatment usually lasts 7 to 10 days. Safety beyond 14 days has not been established. Simple infections often respond within 1 to 2 days. If you are not improving within 3 to 5 days, your doctor should re-check the bacteria.

What side effects should I call about?

Tell your care team right away about hearing changes, ringing in the ears, dizziness or vertigo, much less urine, numbness or tingling, muscle twitching, or trouble breathing. Hearing damage can be permanent and may not cause warning signs, so monitoring is important.

Can I take it with other medicines?

Be careful. Water pills such as furosemide, and drugs like vancomycin, cisplatin, and polymyxin B, can add to ear and kidney damage. Tell your team about everything you take, including anesthetic or muscle relaxant medicines before surgery.

Is amikacin injection safe in pregnancy?

Aminoglycosides can harm an unborn baby. Tell your doctor if you are pregnant or become pregnant. Your doctor will weigh the risk against the need to treat your infection.

What if I miss a dose?

You get this medicine from a healthcare team on a set schedule. If a dose is delayed or missed, tell your nurse or doctor so they can adjust the timing.

Is amikacin injection available over the counter?

No. Amikacin injection is a prescription medicine: every amikacin injection product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was amikacin injection first available?

The earliest FDA record we hold for amikacin injection is from 1981: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when amikacin injection was first used.

Who makes amikacin injection?

6 companies currently list amikacin injection products in the FDA's NDC Directory, including Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., Hikma Pharmaceuticals USA Inc., Mullan Pharmaceutical Inc.. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What is the brand name of amikacin injection?

Amikacin injection is the generic name. Its brand name is Amikin. Generic versions are listed under the name amikacin injection.

What is the generic name of Amikin?

The generic name of Amikin is amikacin injection. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is amikacin injection?

Amikacin injection belongs to the drug class Aminoglycoside Antibacterial, its established pharmacologic class on the FDA label.

Is there a generic version of amikacin injection?

Yes. FDA-approved generic versions of amikacin injection are listed in the FDA's National Drug Code Directory. A listing does not prove that every pharmacy stocks one, so your pharmacy can tell you which version it carries.

What strengths does amikacin injection come in?

Amikacin injection is listed in the FDA's National Drug Code Directory in these forms and strengths. Injection (into a muscle, into a vein): 500 mg/2 mL and 1 g/4 mL. A listing does not mean every pharmacy stocks every strength.

How much does amikacin injection cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, pharmacies paid a national average of $2.57 per mL of the generic injection across 2 strengths as of November 18, 2026 (CMS's NADAC survey). That is the pharmacy's own cost for the medicine, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Where can I read the amikacin injection prescribing information (package insert)?

The full FDA-approved prescribing information for amikacin injection, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Sagent Pharmaceuticals's, revised Jul 27, 2026, and links to it on DailyMed.

Is amikacin injection gluten free?

No amikacin injection label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten, and none names a starch, dextrin or maltodextrin without saying where it comes from. We read the FDA labels of 11 amikacin injection products from 6 companies. A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's amikacin injection by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See amikacin injection inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Amikacin Injection

Skip the scrolling. Ask in your own words and get an answer from Amikacin Injection’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Amikacin Injection’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Amikacin Injection on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Amikacin Injection Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Amikacin Injection Forms and Strengths (How It Comes)

Amikacin Injection comes in 1 dose form, the injection. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Amikacin Injection inactive ingredients by manufacturer.

Injection

Into a muscle · Into a vein
Brands Amikin (the first brand, 1981, discontinued)
How this form is used
What it may be used for
  • Amikacin sulfate injection is used for short-term treatment of serious infections caused by susceptible Gram-negative bacteria.
  • Amikacin sulfate injection may also be used for certain staphylococcal infections.
Important instructions
  • Amikacin sulfate injection may be given into a muscle or into a vein.
  • For IV use, amikacin sulfate is diluted and given to adults over 30 to 60 minutes; infants receive it over 1 to 2 hours.
  • Amikacin sulfate vials are single-dose, and unused portions are discarded.
  • Amikacin sulfate should not be premixed with other drugs.
Available strengths 3 strengths
11 FDA-listed product records ⓘ

Amikacin Injection on the U.S. Market: Products, Makers and Brands

How Amikacin Injection appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

6 companies list 11 Amikacin Injection product records with the FDA, mostly as injection; the earliest marketing or approval year on record is 1981.

1
Dose forms ⓘ
6
Labelers (makers, repackagers, distributors)
1
Brand names ⓘ
11
FDA-listed product records ⓘ
1981
Earliest FDA record ⓘ
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.27%
Hikma Pharmaceuticals USA Inc.18%
Mullan Pharmaceutical Inc.18%
Qilu Pharmaceutical Co., Ltd.18%
Fresenius Kabi USA, LLC9%
Sagent Pharmaceuticals9%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Amikacin Injection Is Used (Medicaid Data)

How many Amikacin Injection prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

2,869
Medicaid prescriptions filled (Q1–Q4 2025)
$123,551 paid by Medicaid, before rebates

How commonly is Amikacin Injection prescribed? Of the 1,682 medications we measure, Amikacin Injection ranks #1,170 by Medicaid prescriptions — more than 30% of them.

Where Amikacin Injection ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Amikacin Injection product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 4 mL / 250 mg/mL injection is the most-dispensed Amikacin Injection product — about 50% of these Medicaid prescriptions.

4 ML amikacin 250 MG/ML Injection Most dispensed

1,438 Medicaid prescriptions (Q1–Q4 2025) 50% of Amikacin Injection prescriptions shown $50,566 paid by Medicaid, before rebates ≈ $35 per prescription, before rebates

5 of 15 listed NDCs had Medicaid claims. RxNorm 1723160

2 ML amikacin 250 MG/ML Injection

1,431 Medicaid prescriptions (Q1–Q4 2025) 50% of Amikacin Injection prescriptions shown $72,985 paid by Medicaid, before rebates ≈ $51 per prescription, before rebates

4 of 15 listed NDCs had Medicaid claims. RxNorm 1723156

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 9 of the 30 listed Amikacin Injection NDCs had Medicaid claims.

Compare Amikacin Injection Products

A representative set of FDA-listed product records for Amikacin Injection — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Strength Route Manufacturer / Labeler Category ⓘ Details
💊Injection
250 mg/mL Intramuscular, Intravenous Fresenius Kabi USA, LLC ANDA View NDC →
250 mg/mL Intramuscular, Intravenous Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. ANDA View NDC →
500 mg/2 mL Intramuscular, Intravenous Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. ANDA View NDC →
1 g/4 mL Intramuscular, Intravenous Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. ANDA View NDC →
250 mg/mL Intramuscular, Intravenous Hikma Pharmaceuticals USA Inc. × 2 listings ANDA View NDC →
250 mg/mL Intramuscular, Intravenous Mullan Pharmaceutical Inc. × 2 listings ANDA View NDC →
250 mg/mL Intramuscular, Intravenous Qilu Pharmaceutical Co., Ltd. × 2 listings ANDA View NDC →
250 mg/mL Intramuscular, Intravenous Sagent Pharmaceuticals ANDA View NDC →

Showing 11 of 11 products — FDA National Drug Code Directory. See every product, package size and price: browse all 11 Amikacin Injection NDCs →

Amikacin Injection Side Effects Reported to the FDA (FAERS)

After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Amikacin Injection — a signal of what to watch for, not proof the drug caused it.

The effects most often named in FDA reports that mention Amikacin Injection are cough, dyspnoea, therapy interrupted; about 84% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.

18,979
Reports mentioning it
84%
Reported as serious
12
Distinct effects shown
Most reported effects
Cough
1,753
Dyspnoea
1,738
Therapy Interrupted
1,438
Hospitalisation
1,419
Death
1,191
Dysphonia
1,049
Nausea
885
Pyrexia
824
Fatigue
794
Pneumonia
789
Age groups
Adult · 1,036Elderly · 571Child · 180Neonate · 171Adolescent · 91Infant · 74

Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Amikacin Injection in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.

Amikacin Injection FDA Approval History

How Amikacin Injection went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.

Amikacin Injection was first approved by the FDA in 1981 (Apothecon). It remains available in U.S. pharmacies today.

1981
First FDA approval
Apothecon
2026
Available today
Active in U.S. pharmacies

Source: Drugs@FDA.

Amikacin Injection Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Amikacin recalls since July 2021.

✅No Amikacin recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Amikacin Injection in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
3
Strengths
6
Forms in current FDA listings
2 of 3
In current FDA listings No current FDA listing
Ingredient (IN) Amikacin Injection RxCUI 641
  1. Dose form (SCDF) Inhalation Suspension RxCUI 2285804
    No current FDA listing
    Its strength (SCD)
  2. Dose form (SCDF) Injectable Solution RxCUI 370563
    In current FDA listings
    Its 3 strengths (SCD)
    • 250 mg/mL RxCUI 1598047
    • 5 mg/mL sulfate RxCUI 905156
    • 50 mg/mL sulfate RxCUI 905148
  3. Dose form (SCDF) Injection RxCUI 1723155
    In current FDA listings
    Its 2 strengths (SCD)

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Amikacin Injection Costs Pharmacies (NADAC Benchmark)

What pharmacies pay to buy Amikacin Injection: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.

How the Pharmacy Price Has Changed

Pick a strength to see how its price has changed since Apr 2025.

Strength

For the generic 250 mg/mL injection, pharmacies paid an average of $2.57 per mL as of Nov 18, 2026, down 13% from $2.96 a year earlier.

What pharmacies pay now
$2.57
per mL, as of Nov 18, 2026
Last 4 weeks
Up 5.6%
from $2.43 on Oct 21, 2026
Last 12 months
Down 13%
from $2.96 on Nov 19, 2025
Lowest and highest since Apr 2025
$2.27 to $3.21
per mL

Each step is one weekly survey. Arrow keys on the chart move week by week.
See the numbers, month by month
Generic 250 mg/mL injection: the average pharmacy price per mL, the last survey of each month
MonthPharmacy price
Nov 2026$2.57
Oct 2026$2.43
Sep 2026$2.33
Aug 2026$2.30
Jul 2026$2.27
Jun 2026$2.27
May 2026$2.72
Apr 2026$2.72
Mar 2026$2.72
Feb 2026$2.72
Jan 2026$2.72
Dec 2025$2.72
Nov 2025$2.96
Oct 2025$2.87
Sep 2025$3.03
Aug 2025$3.02
Jul 2025$3.21
Jun 2025$3.15
May 2025$3.15
Apr 2025$3.05
FormStrengthVersion What pharmacies pay
Injection · Intramuscular, Intravenous 250 mg/mL Generic $2.57 per mL NDC details & price history
Injection · Intramuscular, Intravenous 500 mg/2 mL Generic $2.57 per mL NDC details & price history
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.

Amikacin Injection Brand Names

Amikacin Injection has one brand name on record: Amikin. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Amikin the first brand, 1981, discontinued

Who Makes Amikacin Injection: Manufacturers and Labelers

6 companies list Amikacin Injection products with the FDA. By number of product records, the largest are Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., Hikma Pharmaceuticals USA Inc., Mullan Pharmaceutical Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 3 Hikma Pharmaceuticals USA Inc. 2 Mullan Pharmaceutical Inc. 2 Qilu Pharmaceutical Co., Ltd. 2 Fresenius Kabi USA, LLC 1 Sagent Pharmaceuticals 1

Sources for This Amikacin Injection Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Jul 27, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Amikacin Injection.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 7 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
7
Finished products in the current FDA directory
11
Companies listing them (makers, repackagers, distributors)
6
FDA labeler codes behind them ⓘ
6
Linked representative label ⓘ
Sagent Pharmaceuticals
Linked label effective
Jul 27, 2026
Composite sections available
18
Linked SPL Set ID
f260ff2a-76a0-4672-9516-91c344b67890
Linked SPL Document ID
199988b6-2417-4072-803d-fa6acab5703f
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Sagent Pharmaceuticals is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →